scholarly journals OlympiAD: Health-related quality of life (HRQoL) in patients with HER2-negative metastatic breast cancer (mBC) and a germline BRCA mutation (gBRCAm) receiving olaparib monotherapy vs standard single-agent chemotherapy treatment of physician’s choice (TPC)

2017 ◽  
Vol 28 ◽  
pp. v96 ◽  
Author(s):  
M. Robson ◽  
K.J. Ruddy ◽  
S-A. Im ◽  
E. Senkus-Konefka ◽  
B. Xu ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document